Recombinant coagulation factor X - VarmX

Drug Profile

Recombinant coagulation factor X - VarmX

Alternative Names: Factor Xa inhibitor reversal agent - VarmX; Modified blood coagulation factor X - VarmX; PseudoXa

Latest Information Update: 05 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator VarmX
  • Class Antihaemorrhagics; Blood coagulation factors; Coagulants; Recombinant proteins
  • Mechanism of Action Blood coagulation factor replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Haemorrhage

Most Recent Events

  • 27 Jun 2017 Preclinical trials in Haemorrhage (Prevention and Treatment) in Netherlands (unspecified route) before June 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top